Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Individual Investigator Research Awards

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Competitive renewal applications accepted.

Award: Up to $350,000 per year. Exceptions permitted if extremely well justified; maximum duration: 3 years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Cancer in Children and Adolescents

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near or long term. Competitive renewal applications accepted.

Award: Up to $350,000 per year. Applicants that plan on conducting a clinical trial as part of the project may request up to $500,000 in total costs. Exceptions permitted if extremely well justified; maximum duration: 4 years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Clinical Translation

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications that propose innovative cancer clinical studies that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices.

Award: Up to $500,000 per year. Maximum duration: 4 years.   Exceptions permitted if extremely well justified.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Computational Systems Biology of Cancer

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative mathematical and/or computational research projects addressing questions that will advance current knowledge in the (a) mechanisms that tie altered gene expression and downstream molecular mechanisms to functional cancer phenotypes and/or (b) mechanisms that tie tumor morphology to functional cancer phenotypes and/or mechanisms that tie treatment sequence and combination to evolving functional cancer phenotypes (that emerge as a result of treatment selection).

Award: Up to $400,000 in total costs per year for up to 3 years. Exceptions permitted if extremely well justified.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Prevention and Early Detection

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications which propose clinical and population-based projects designed to develop effective prevention and early detection interventions to reduce cancer risk, mortality, and morbidity among Texans. Projects that propose such research collaborations with existing CPRIT Prevention Program awardees including the CPRIT funded Texas Collaborative Center for Hepatocellular Cancer (https://www.bcm.edu/research/labs-and-centers/research-centers/texas-collaborative-center-for-hepatocellular-cancer) are strongly encouraged. 

Award: Up to $500,000 per year. Exceptions permitted if extremely well justified; maximum duration: 4 years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Recruitment of Established Investigators

Revised: 10/26/2020

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Revised: 09/24/2020

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million up to a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous

Recruitment of Rising Stars

Revised: 10/26/2020

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research.

Award: Up to $4 million over a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous